Literature DB >> 18625443

Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?

Helen R Griffiths1.   

Abstract

Biomolecules are susceptible to many different post-translational modifications that have important effects on their function and stability, including glycosylation, glycation, phosphorylation and oxidation chemistries. Specific conversion of aspartic acid to its isoaspartyl derivative or arginine to citrulline leads to autoantibody production in models of rheumatoid disease, and ensuing autoantibodies cross-react with native antigens. Autoimmune conditions associate with increased activation of immune effector cells and production of free radical species via NADPH oxidases and nitric oxide synthases. Generation of neo-antigenic determinants by reactive oxygen and nitrogen species ROS and RNS) may contribute to epitope spreading in autoimmunity. The oxidation of amino acids by peroxynitrite, hypochlorous acid and other reactive oxygen species (ROS) increases the antigenicity of DNA, LDL and IgG, generating ligands for which autoantibodies show higher avidity. This review focuses on the evidence for ROS and RNS in promoting the autoimmune responses observed in diseases rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). It considers the evidence for ROS/RNS-induced antigenicity arising as a consequence of failure to remove or repair ROS/RNS damaged biomolecules and suggests that an associated defect, probably in T cell signal processing or/or antigen presentation, is required for the development of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625443     DOI: 10.1016/j.autrev.2008.04.013

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  36 in total

1.  Therapeutic effect of Withania somnifera on pristane-induced model of SLE.

Authors:  Ujla Minhas; Ranjana Minz; Prabir Das; Archana Bhatnagar
Journal:  Inflammopharmacology       Date:  2011-12-13       Impact factor: 4.473

Review 2.  Atherosclerosis and autoimmunity.

Authors:  Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

3.  Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.

Authors:  Nadine Glesse; Paula Rohr; Odirlei André Monticielo; Tássia Flores Rech; João Carlos Tavares Brenol; Ricardo Machado Xavier; Kátia Kvitko; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

Review 4.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

5.  iNOS null MRL+/+ mice show attenuation of trichloroethene-mediated autoimmunity: contribution of reactive nitrogen species and lipid-derived reactive aldehydes.

Authors:  Gangduo Wang; Maki Wakamiya; Jianling Wang; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2015-11-04       Impact factor: 7.376

6.  Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.

Authors:  Abdul Hakkim; Barbara G Fürnrohr; Kerstin Amann; Britta Laube; Ulrike Abu Abed; Volker Brinkmann; Martin Herrmann; Reinhard E Voll; Arturo Zychlinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

7.  Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Elvira Kurmaeva; Dmitry Ostanin; D Neil Granger
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

8.  Human single-chain variable fragment that specifically targets arthritic cartilage.

Authors:  Chris Hughes; Bjarne Faurholm; Francesco Dell'Accio; Antonio Manzo; Michael Seed; Noha Eltawil; Alessandra Marrelli; David Gould; Christina Subang; Adam Al-Kashi; Cosimo De Bari; Paul Winyard; Yuti Chernajovsky; Ahuva Nissim
Journal:  Arthritis Rheum       Date:  2010-04

Review 9.  Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Authors:  Valerian E Kagan; Peter Wipf; Detcho Stoyanovsky; Joel S Greenberger; Grigory Borisenko; Natalia A Belikova; Naveena Yanamala; Alejandro K Samhan Arias; Muhammad A Tungekar; Jianfei Jiang; Yulia Y Tyurina; Jing Ji; Judith Klein-Seetharaman; Bruce R Pitt; Anna A Shvedova; Hülya Bayir
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

10.  Rebamipide attenuates autoimmune arthritis severity in SKG mice via regulation of B cell and antibody production.

Authors:  J-K Byun; S-J Moon; J-Y Jhun; E-K Kim; J-S Park; J Youn; J-K Min; S-H Park; H-Y Kim; M-L Cho
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.